Why is P & G Health Ltd falling/rising?

As of 19-Sep, Procter & Gamble Health Ltd's stock price is currently at 6,337.50, reflecting an increase of 86.3 points or 1.38%. Today's performance indicates that the stock has outperformed its sector by 1.11% and has shown a trend reversal after two consecutive days of decline, reaching an intraday high of Rs 6400. Over the past week, the stock has gained 1.48%, while its year-to-date performance stands at an impressive 21.17%. Despite a recent decline in investor participation, as evidenced by a 27.19% drop in delivery volume, the company boasts strong fundamentals, including a high return on equity of 32.32%, low debt levels, and consistent positive results over the last four quarters, which have likely contributed to the stock's upward movement.
In the broader market context, Procter & Gamble Health Ltd has outperformed the Sensex, which has increased by only 0.88% over the past week. The stock's ability to generate a 24.30% return over the last year, compared to the Sensex's decline of 0.67%, highlights its strong market position. However, there are concerns regarding its long-term growth potential, as net sales have only grown at an annual rate of 7.39% over the past five years, and the stock is considered expensive with a price-to-book value of 19.6. While the stock's recent performance is bolstered by high institutional holdings and management efficiency, these factors must be weighed against the risks of slower growth and high valuation.